| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Geovax Labs, Inc. (GOVX) has 11 insiders with recent SEC Form 4 filings, including 10 buys and 0 sells. GOVX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 185.5K | $246.7K | - | |
| Other | 70.0K | $93.1K | - | |
| VP | 70.0K | $93.1K | - | |
| CFO | 70.0K | $93.1K | - | |
| Dir | 21.4K | $28.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 25, 2023 | McKee Kelly T. Jr. | Chief Medical Officer | Buy | 9,653 | $0.52 | $5,019.56 | +50.3% | |
| Aug 25, 2023 | Dodd David A | President, CEO | Buy | 35,087 | $0.57 | $19,999.59 | +30.8% | |
| Aug 18, 2023 | Reynolds Mark | CFO | Buy | 10,000 | $0.52 | $5,179.00 | +14.7% | |
| Apr 24, 2023 | Dodd David A | President, CEO | Buy | 32,000 | $0.64 | $20,444.80 | +39.1% | |
| Apr 20, 2023 | Reynolds Mark | CFO | Buy | 8,000 | $0.63 | $5,040.00 | +13.3% | |
| Sep 21, 2022 | Chase Randal D | Director | Buy | 10,000 | $1.10 | $11,000.00 | +37.6% | |
| Jul 1, 2022 | Sharkey John W. | VP, Business Development | Buy | 1,000 | $0.82 | $820.00 | +53.8% | |
| Jun 27, 2022 | McKee Kelly T. Jr. | Chief Medical Officer | Buy | 4,464 | $1.12 | $4,999.68 | +30.3% | |
| Jun 21, 2022 | Chase Randal D | Director | Buy | 10,000 | $1.21 | $12,100.00 | +60.2% | |
| May 5, 2022 | McKee Kelly T. Jr. | Chief Medical Officer | Buy | 9,722 | $0.72 | $6,999.84 | +194.5% |